Cormorant Asset Management
The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 17 rounds in the feed, most often at Series B and in Biotech.
Cormorant Asset Management, LP is a life sciences and healthcare focused investment firm, founded by Bihua Chen in 2013. Cormorant primarily invests in biotechnology companies across the public and private markets.
Venture capitalcormorant-asset.comRounds from 2020-03-05 to 2026-10-28
ROUNDS
17
led 5, joined 12
LED ROUNDS · USD
$235M
across 5 rounds · 4 co-led, split evenly
CO-INVESTORS
94
most often with OrbiMed